GlaxoSmithKline to invest zl. 63 million in Poznan plant

British concern GlaxoSmithKline (GSK), one of the world's largest manufacturers of medicines with a global market share estimated at 7%, intends to launch production of a new pharmaceutical at its Poznan factory. The investment, worth zl. 63 million, is planned to commence in 2007 and is expected to provide 40 new jobs. The new drug, details of which remain unknown, will be exported to many countries around the world and will transform the Poznan factory into GSK's sixth largest site in Europe. In 1998, GSK became the strategic investor in Polfa Poznan and has to date spent zl. 1.6 billion on the factory's development. Presently, GSK employs 1,600 people in Poland, the majority of whom work at the Poznan factory. (Puls Biznesu, p.10) K.Z.